Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults. Chen GL, Yu XY, Luo LP, Zhang F, et al. Vaccine 2023 Nov 2:S0264-410X(23)01278-1. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Chen GL, Yu XY, Luo LP, Zhang F, et al. Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults. Vaccine 2023 Nov 2:S0264-410X(23)01278-1. doi: 10.1016/j.vaccine.2023.
PMID: 37925316